Structural surfaceomics reveals an AML-specific conformation of integrin β 2 as a CAR T cellular therapy target.

Autor: Mandal K; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA., Wicaksono G; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA., Yu C; Department of Physiology and Biophysics, University of California Irvine, Irvine, CA, USA., Adams JJ; The Donnelly Centre, University of Toronto, Toronto, Ontario, Canada.; School of Pharmacy, University of Waterloo, Kitchener, Ontario, Canada., Hoopmann MR; Institute for Systems Biology, Seattle, WA, USA., Temple WC; Department of Pediatrics, Division of Hematology/Oncology, University of California San Francisco, San Francisco, CA, USA.; Department of Pediatrics, Division of Allergy, Immunology, and Bone Marrow Transplantation, University of California San Francisco, San Francisco, CA, USA., Izgutdina A; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA., Escobar BP; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA., Gorelik M; The Donnelly Centre, University of Toronto, Toronto, Ontario, Canada., Ihling CH; Department of Pharmaceutical Chemistry and Bioanalytics, Institute of Pharmacy, Martin-Luther University Halle-Wittenberg, Halle, Germany., Nix MA; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA., Naik A; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA., Xie WH; UCSF/Gladstone Institute for Genomic Immunology, San Francisco, CA, USA., Hübner J; Department of Pediatrics, Division of Hematology/Oncology, University of California San Francisco, San Francisco, CA, USA.; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA., Rollins LA; Center for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital-Texas Children's Hospital, Houston, TX, USA., Reid SM; Center for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital-Texas Children's Hospital, Houston, TX, USA., Ramos E; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA., Kasap C; Department of Medicine, Division of Hematology/Oncology, University of California San Francisco, San Francisco, CA, USA., Steri V; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA., Serrano JAC; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA., Salangsang F; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA., Phojanakong P; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA., McMillan M; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA., Gavallos V; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA., Leavitt AD; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA., Logan AC; Department of Medicine, Division of Hematology/Oncology, University of California San Francisco, San Francisco, CA, USA., Rooney CM; Center for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital-Texas Children's Hospital, Houston, TX, USA., Eyquem J; UCSF/Gladstone Institute for Genomic Immunology, San Francisco, CA, USA.; Department of Medicine, Division of Hematology/Oncology, University of California San Francisco, San Francisco, CA, USA., Sinz A; Department of Pharmaceutical Chemistry and Bioanalytics, Institute of Pharmacy, Martin-Luther University Halle-Wittenberg, Halle, Germany., Huang BJ; Department of Pediatrics, Division of Hematology/Oncology, University of California San Francisco, San Francisco, CA, USA., Stieglitz E; Department of Pediatrics, Division of Hematology/Oncology, University of California San Francisco, San Francisco, CA, USA.; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA., Smith CC; Department of Medicine, Division of Hematology/Oncology, University of California San Francisco, San Francisco, CA, USA., Moritz RL; Institute for Systems Biology, Seattle, WA, USA., Sidhu SS; The Donnelly Centre, University of Toronto, Toronto, Ontario, Canada.; School of Pharmacy, University of Waterloo, Kitchener, Ontario, Canada., Huang L; Department of Physiology and Biophysics, University of California Irvine, Irvine, CA, USA., Wiita AP; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA. arun.wiita@ucsf.edu.; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. arun.wiita@ucsf.edu.; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA. arun.wiita@ucsf.edu.; Chan Zuckerberg Biohub San Francisco, San Francisco, CA, USA. arun.wiita@ucsf.edu.

Publikováno v: Nature cancer [Nat Cancer] 2023 Nov; Vol. 4 (11), pp. 1592-1609. Date of Electronic Publication: 2023 Oct 30.

Development of CD46 targeted alpha theranostics in prostate cancer using ¹³⁴Ce/²²⁵Ac-Macropa-PEG4-YS5.

Autor: Bobba, Kondapa Naidu, Bidkar, Anil P., Wadhwa, Anju, Meher, Niranjan, Drona, Suchi, Sorlin, Alexandre M., Bidlingmaier, Scott, Li Zhang, Wilson, David M., Emily Chan, Greenland, Nancy Y., Aggarwal, Rahul, VanBrocklin, Henry F., Jiang He, Jonathan Chou, Youngho Seo, Bin Liu, Flavell, Robert R.

Publikováno v: Theranostics; 2024, Vol. 14 Issue 4, p1344-1360, 17p

SARS-CoV-2/COVID-19 and advances in developing potential therapeutics and vaccines to counter this emerging pandemic.

Autor: Rabaan, Ali A., Al-Ahmed, Shamsah H., Sah, Ranjit, Tiwari, Ruchi, Yatoo, Mohd. Iqbal, Patel, Shailesh Kumar, Pathak, Mamta, Malik, Yashpal Singh, Dhama, Kuldeep, Singh, Karam Pal, Bonilla-Aldana, D. Katterine, Haque, Shafiul, Martinez-Pulgarin, Dayron F., Rodriguez-Morales, Alfonso J., Leblebicioglu, Hakan

Publikováno v: Annals of Clinical Microbiology & Antimicrobials; 9/2/2020, Vol. 19 Issue 1, p1-37, 37p